StemTech International Sdn Bhd (‘StemTech International’) is dedicated and committed to cord blood and adult stem cell banking (collection/harvesting, processing and storage), stem cell medical therapy, as well as R&D for the purpose of future stem cell technology improvements and medical therapy.

StemTech International is a subsidiary of TMC Life Sciences Berhad (‘TMC Group’), a company listed on the Main Board of Bursa Malaysia Securities Berhad (Stock Code: TMCLIFE 0101, Bloomberg: TMCL MK). TMC Group is reputed to be the leading fertility treatment services provider in this region, and ranked among the best in the world in achieving consistently-high pregnancy success rates. Its flagship full-fledged tertiary hospital, Tropicana Medical Centre, aims to provide premium healthcare services.

In collaboration with Tropicana Medical Centre, StemTech International will be the only stem cell services provider in Malaysia with its own hospital-based stem cell therapy centre, and be well-positioned to deliver stem cell medical therapy to its valued clients.